Mexico has the second-largest pharmaceutical market in Latin America and ranks 12th globally. As an important producer of medicines, including antibiotics, anti-inflammatories and cancer treatments among others, Mexico is projected to reach over USD $13 billion in pharmaceutical sales by 2028.
Regulatory oversight of pharmaceutical industry promotional activities has increased in recent years. While Mexico does not have an official regulatory code for public relations in the health sector, these activities must abide by the regulations that are in place for advertising.
TO Market Access
Sign up to get the guides
Select the guides you wish to download
Our office in Mexico
GHMC has long-standing relationships within Mexico to deliver deep local insights and flawlessly execute programs across this important Latin American market.